Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Completed

A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer

NCT03785925

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +17 more
Locations
  • San Francisco VA Medical Center - NAVREF - PPDS San Francisco, California, United States
  • Innovative Clinical Research Institute, LLC Whittier, California, United States
  • Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
View all 70 locations
View Trial Details
Completed

A Dose Escalation and Cohort Expansion Study of NKTR-214 in Combination With Nivolumab and Other Anti-Cancer Therapies in Patients With Select Advanced Solid Tumors

NCT02983045

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +55 more
Locations
  • UCSD, Moores Cancer Center La Jolla, California, United States
  • UCLA Los Angeles, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • University of Colorado, Denver Denver, Colorado, United States
View all 58 locations
View Trial Details
Completed

A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors

NCT03517488

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +129 more
Locations
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute Los Angeles, California, United States
  • UCLA Hematology-Oncology Clinic (Westwood) Los Angeles, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
View all 17 locations
View Trial Details
Completed

Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)

NCT03980041

Conditions
Advanced Cancer, Bladder Cancer, Carcinoma, +16 more
Locations
  • Parkview Physicians Fort Wayne, Indiana, United States
  • University of MD - Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Karmanos Cancer Center Detroit, Michigan, United States
  • Coborn Cancer Center Saint Cloud, Minnesota, United States
View all 29 locations
View Trial Details

Related conditions